TScan Therapeutics (TCRX) Stock Price
TScan Therapeutics Price
Over the last 5 years TScan Therapeutics grew revenue by 56.9% annually, reaching 10.33 M USD. For TScan Therapeutics, the net margin of -1,256.8% is down versus -479.5% a few years ago.
TScan Therapeutics stock price
TScan Therapeutics business model & stock analysis
Frequently asked questions about TScan Therapeutics
13 analysts currently rate the TScan Therapeutics stock: 10 recommend buying, 3 holding and 0 selling. For 2026, analysts expect TScan Therapeutics to generate revenue of 2.91 M USD and earnings per share of -0.35 USD.
Converted at the current exchange rate, the TScan Therapeutics share trades at 0.21 EUR (0.23 USD).
The TScan Therapeutics share (TCRX) is listed on 1 stock exchanges, including: NASDAQ (TCRX).
The expected revenue of TScan Therapeutics is 2.91 M USD. This figure is based on current financial data and reflects the company's business performance.
The expected profit of TScan Therapeutics is -45.15 M USD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of TScan Therapeutics is currently -0.66. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the TScan Therapeutics stock.
The price-to-sales ratio (P/S) of TScan Therapeutics is currently 10.29. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the TScan Therapeutics stock.
The Eulerpool Quality Score for TScan Therapeutics is 2/10.
The ISIN of TScan Therapeutics is US89854M1018. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of TScan Therapeutics is TCRX. The ticker symbol is used to trade TScan Therapeutics shares on the stock exchange.
TScan Therapeutics stock
TScan Therapeutics Peer Group
TScan Therapeutics Ticker
TScan Therapeutics FIGI
All fundamentals and in-depth analysis of TScan Therapeutics
Our stock analysis for TScan Therapeutics stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of TScan Therapeutics. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.